![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ID3 |
Gene summary for ID3 |
![]() |
Gene information | Species | Human | Gene symbol | ID3 | Gene ID | 3399 |
Gene name | inhibitor of DNA binding 3, HLH protein | |
Gene Alias | HEIR-1 | |
Cytomap | 1p36.12 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q02535 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3399 | ID3 | CA_HPV_1 | Human | Cervix | CC | 1.06e-02 | -1.30e-01 | 0.0264 |
3399 | ID3 | CCI_3 | Human | Cervix | CC | 6.91e-04 | -2.96e-01 | 0.516 |
3399 | ID3 | CCII_1 | Human | Cervix | CC | 7.15e-04 | -2.84e-01 | 0.3249 |
3399 | ID3 | Tumor | Human | Cervix | CC | 2.67e-11 | 4.82e-01 | 0.1241 |
3399 | ID3 | sample1 | Human | Cervix | CC | 2.63e-14 | 8.70e-01 | 0.0959 |
3399 | ID3 | sample3 | Human | Cervix | CC | 5.91e-16 | 4.38e-01 | 0.1387 |
3399 | ID3 | T1 | Human | Cervix | CC | 1.58e-26 | 9.00e-01 | 0.0918 |
3399 | ID3 | T3 | Human | Cervix | CC | 2.57e-14 | 4.50e-01 | 0.1389 |
3399 | ID3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 9.19e-15 | 5.21e-01 | 0.0155 |
3399 | ID3 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.33e-16 | 7.17e-01 | -0.1808 |
3399 | ID3 | HTA11_2951_2000001011 | Human | Colorectum | AD | 8.51e-18 | 1.09e+00 | 0.0216 |
3399 | ID3 | HTA11_1938_2000001011 | Human | Colorectum | AD | 7.38e-19 | 1.18e+00 | -0.0811 |
3399 | ID3 | HTA11_78_2000001011 | Human | Colorectum | AD | 9.20e-18 | 6.55e-01 | -0.1088 |
3399 | ID3 | HTA11_347_2000001011 | Human | Colorectum | AD | 5.59e-33 | 8.45e-01 | -0.1954 |
3399 | ID3 | HTA11_411_2000001011 | Human | Colorectum | SER | 3.31e-03 | 9.86e-01 | -0.2602 |
3399 | ID3 | HTA11_2112_2000001011 | Human | Colorectum | SER | 2.09e-03 | 7.80e-01 | -0.2196 |
3399 | ID3 | HTA11_3361_2000001011 | Human | Colorectum | AD | 7.27e-26 | 1.20e+00 | -0.1207 |
3399 | ID3 | HTA11_83_2000001011 | Human | Colorectum | SER | 4.48e-19 | 8.51e-01 | -0.1526 |
3399 | ID3 | HTA11_696_2000001011 | Human | Colorectum | AD | 8.65e-35 | 1.10e+00 | -0.1464 |
3399 | ID3 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.62e-22 | 6.10e-01 | -0.1001 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00062605 | Skin | AK | DNA replication | 40/1910 | 260/18723 | 5.49e-03 | 3.03e-02 | 40 |
GO:00720018 | Skin | AK | renal system development | 45/1910 | 302/18723 | 6.14e-03 | 3.31e-02 | 45 |
GO:00454455 | Skin | AK | myoblast differentiation | 16/1910 | 84/18723 | 1.01e-02 | 4.84e-02 | 16 |
GO:000626012 | Skin | cSCC | DNA replication | 106/4864 | 260/18723 | 1.18e-07 | 2.77e-06 | 106 |
GO:000762323 | Skin | cSCC | circadian rhythm | 89/4864 | 210/18723 | 1.55e-07 | 3.51e-06 | 89 |
GO:003292222 | Skin | cSCC | circadian regulation of gene expression | 37/4864 | 68/18723 | 5.65e-07 | 1.08e-05 | 37 |
GO:000164923 | Skin | cSCC | osteoblast differentiation | 89/4864 | 229/18723 | 1.18e-05 | 1.51e-04 | 89 |
GO:004851123 | Skin | cSCC | rhythmic process | 110/4864 | 298/18723 | 1.83e-05 | 2.19e-04 | 110 |
GO:000150323 | Skin | cSCC | ossification | 137/4864 | 408/18723 | 3.39e-04 | 2.68e-03 | 137 |
GO:00062755 | Skin | cSCC | regulation of DNA replication | 44/4864 | 107/18723 | 4.41e-04 | 3.39e-03 | 44 |
GO:004544513 | Skin | cSCC | myoblast differentiation | 35/4864 | 84/18723 | 1.23e-03 | 7.97e-03 | 35 |
GO:00713988 | Skin | cSCC | cellular response to fatty acid | 17/4864 | 38/18723 | 9.41e-03 | 4.25e-02 | 17 |
GO:00713985 | Stomach | GC | cellular response to fatty acid | 9/1159 | 38/18723 | 4.12e-04 | 6.25e-03 | 9 |
GO:00705424 | Stomach | GC | response to fatty acid | 11/1159 | 64/18723 | 1.75e-03 | 1.83e-02 | 11 |
GO:00076235 | Stomach | GC | circadian rhythm | 23/1159 | 210/18723 | 5.64e-03 | 4.34e-02 | 23 |
GO:00713981 | Stomach | CAG with IM | cellular response to fatty acid | 8/1050 | 38/18723 | 1.03e-03 | 1.29e-02 | 8 |
GO:00705421 | Stomach | CAG with IM | response to fatty acid | 10/1050 | 64/18723 | 2.82e-03 | 2.69e-02 | 10 |
GO:00713982 | Stomach | CSG | cellular response to fatty acid | 8/1034 | 38/18723 | 9.35e-04 | 1.22e-02 | 8 |
GO:00705422 | Stomach | CSG | response to fatty acid | 10/1034 | 64/18723 | 2.52e-03 | 2.46e-02 | 10 |
GO:000762311 | Stomach | CSG | circadian rhythm | 21/1034 | 210/18723 | 6.27e-03 | 4.86e-02 | 21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04350 | Colorectum | SER | TGF-beta signaling pathway | 31/1580 | 108/8465 | 7.00e-03 | 3.77e-02 | 2.74e-02 | 31 |
hsa043501 | Colorectum | SER | TGF-beta signaling pathway | 31/1580 | 108/8465 | 7.00e-03 | 3.77e-02 | 2.74e-02 | 31 |
hsa043504 | Endometrium | AEH | TGF-beta signaling pathway | 26/1197 | 108/8465 | 3.82e-03 | 2.18e-02 | 1.59e-02 | 26 |
hsa0435011 | Endometrium | AEH | TGF-beta signaling pathway | 26/1197 | 108/8465 | 3.82e-03 | 2.18e-02 | 1.59e-02 | 26 |
hsa043502 | Endometrium | EEC | TGF-beta signaling pathway | 26/1237 | 108/8465 | 5.95e-03 | 3.12e-02 | 2.33e-02 | 26 |
hsa043503 | Endometrium | EEC | TGF-beta signaling pathway | 26/1237 | 108/8465 | 5.95e-03 | 3.12e-02 | 2.33e-02 | 26 |
hsa043507 | Esophagus | ESCC | TGF-beta signaling pathway | 69/4205 | 108/8465 | 1.92e-03 | 5.54e-03 | 2.84e-03 | 69 |
hsa0435014 | Esophagus | ESCC | TGF-beta signaling pathway | 69/4205 | 108/8465 | 1.92e-03 | 5.54e-03 | 2.84e-03 | 69 |
hsa043506 | Oral cavity | OSCC | TGF-beta signaling pathway | 60/3704 | 108/8465 | 8.66e-03 | 1.97e-02 | 1.00e-02 | 60 |
hsa0435013 | Oral cavity | OSCC | TGF-beta signaling pathway | 60/3704 | 108/8465 | 8.66e-03 | 1.97e-02 | 1.00e-02 | 60 |
hsa0435021 | Prostate | Tumor | TGF-beta signaling pathway | 39/1791 | 108/8465 | 2.33e-04 | 1.35e-03 | 8.39e-04 | 39 |
hsa0435031 | Prostate | Tumor | TGF-beta signaling pathway | 39/1791 | 108/8465 | 2.33e-04 | 1.35e-03 | 8.39e-04 | 39 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ID3 | SNV | Missense_Mutation | novel | c.290N>C | p.Leu97Pro | p.L97P | Q02535 | protein_coding | deleterious(0.03) | benign(0.003) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
ID3 | SNV | Missense_Mutation | rs201368186 | c.73N>A | p.Ala25Thr | p.A25T | Q02535 | protein_coding | deleterious(0.05) | possibly_damaging(0.51) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ID3 | SNV | Missense_Mutation | novel | c.328N>G | p.Ile110Val | p.I110V | Q02535 | protein_coding | tolerated(0.77) | benign(0) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ID3 | SNV | Missense_Mutation | rs777214087 | c.38C>T | p.Ala13Val | p.A13V | Q02535 | protein_coding | tolerated(0.29) | possibly_damaging(0.57) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
ID3 | SNV | Missense_Mutation | novel | c.97N>T | p.Ala33Ser | p.A33S | Q02535 | protein_coding | tolerated(0.56) | benign(0.05) | TCGA-55-8621-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ID3 | SNV | Missense_Mutation | c.316C>T | p.Pro106Ser | p.P106S | Q02535 | protein_coding | tolerated(1) | benign(0) | TCGA-55-A4DF-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ID3 | SNV | Missense_Mutation | novel | c.211N>A | p.Gln71Lys | p.Q71K | Q02535 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-37-3792-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ID3 | SNV | Missense_Mutation | novel | c.338A>T | p.Asp113Val | p.D113V | Q02535 | protein_coding | deleterious(0) | benign(0.155) | TCGA-98-A53A-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ID3 | SNV | Missense_Mutation | c.284C>A | p.Pro95His | p.P95H | Q02535 | protein_coding | tolerated(0.34) | benign(0.068) | TCGA-HJ-7597-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | CR |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |